readthroughSign in
CompanyCATXNYSESeattle, WA

Perspective Therapeutics

Perspective Therapeutics develops radiopharmaceutical therapies using alpha-emitting isotope 212Pb paired with imaging agents for personalized cancer treatment.

SCHEDULE 13G/ANov 16Latest SEC filing
Nov 13Latest story